Pharmafield Group: An international dimension

Pharmafield is strengthening its international reach through its partnership with the Ashfield Group. Its CEO, Benjamin Levistre, discusses the strategic rationale behind this long‑term alliance, which brings benefits on several levels for both companies and their laboratory clients.

Discover the press release published in the Pharmaceuticals press review.

Read the PHARMACEUTIQUES® advertorial

When did you enter into this partnership and what motivated it?

For over three years, Pharmafield and Ashfield have been building strong relationships and partnerships with numerous international laboratories. Today, we are finalizing a Franco‑international alliance to optimize, standardize, and offer our partners the joint expertise of our two groups. Thus, we aim to provide increasingly efficient solutions to healthcare companies.

How is this a win‑win partnership for both your companies?

This partnership is enriched, first and foremost, by the sharing of our best practices. Furthermore, the alliance propels Pharmafield onto the international stage for product medical information. In return, Ashfield gains the assurance of benefiting from a certified reference representation for their group in France. We have developed a quality and commitment charter guaranteeing the standardization of services in all European countries. This allows us to offer a range of differentiated and high‑value‑added expertise in each country concerned.

What are the benefits for your laboratory clients?

A strong interest for our laboratory clients is to benefit from international expertise right now. For example, a French laboratory recently contacted us for support in setting up in Latin America. Our innovations, strategies, and medical communication solutions are now offered to the pharmaceutical companies we work with. As in the case of a laboratory wishing to set up in France, since January, we have been offering all our foreign laboratory partners a complete support solution, from company operations through Market Access, to the laboratory's product and institutional strategy and the most appropriate information and promotion solution.

An example of a particular service?

Today—and this is a very long‑term trend—laboratories are calling on our expertise in analysis and market access to best estimate ROI and work on relevant forecasts. The communication about our capabilities and equipment in this area has not only been well understood, but also well received, because it meets a real need, with practical and adapted solutions. Let's take the example of a laboratory, which has a one‑off analysis need for a product launch, the reevaluation of a strategy, or other. Acquiring resources in terms of data, personnel, or even software packages would be an expensive investment. This is why we offer the alternative of Pharmafield expertise, which intervenes according to needs and always in synergy with the client laboratory.

What are the objectives and prospects for this long‑term partnership?

The goal, shared by both groups, is to validate a common basis that will allow laboratories, in search of solutions, to project themselves beyond their natural operating area. And this, while respecting the specificities, and even the culture, of each country.

Indeed, when meeting with subsidiaries in the United Kingdom or Germany, the approaches, strategies, and regulations are radically different from one country to another. Therefore, and through this partnership, we aim to offer laboratories or companies not only expertise and quality processes that can be projected internationally, but also to be facilitators as close as possible to their needs, at the local level.